Shares of this small-cap pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs) surged xx percent on launching the first and only oncology drug approved for neck and head cancer in India first neck.  Price Variation  In Thursday’s trading session, Dr Reddys Laboratories Ltd‘s shares reached an intra-day high … Continue reading Pharma stock in focus after it launches India’s first neck & head cancer treatment drug